M1-NP1 interfering-peptide inhibits cancer cell proliferation and migration by targeting the transcription factor FOXM1

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Pharmaceutical Analysis

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jpha.2025.101493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems

  2024cited by this paper
• The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities

  2024cited by this paper
• Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics.

  2023cited by this paper
• Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles

  2023cited by this paper
• Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1

  2023cited by this paper
• Targeting endothelial permeability in the EPR effect.

  2023cited by this paper
• The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1

  2023cited by this paper
• A first-in-class inhibitor of ER coregulator PELP1 targets ER+ breast cancer.

  2022cited by this paper
• Recent Applications of Retro-Inverso Peptides

  2021cited by this paper
• The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3

  2019cited by this paper
• Targeting transcription factors in cancer — from undruggable to reality

  2019cited by this paper
• Survivin at a glance

  2019cited by this paper
• An order-to-disorder structural switch activates the FoxM1 transcription factor

  2019cited by this paper
• Targeting Transcription Factors for Cancer Treatment

  2018cited by this paper
• Regulation of the master regulator FOXM1 in cancer

  2018cited by this paper
• Regulation of selective autophagy: the p62/SQSTM1 paradigm.

  2017cited by this paper
• High-resolution global peptide-protein docking using fragments-based PIPER-FlexPepDock

  2017cited by this paper
• Interfering peptides targeting protein-protein interactions: the next generation of drugs?

  2017cited by this paper
• Flex ddG: Rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation

  2017cited by this paper
• CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II.

  2017cited by this paper
• Rab1 in Cell Signaling, Cancer and Other Diseases

  2016cited by this paper
• Peptide therapeutics: current status and future directions.

  2015cited by this paper
• Therapeutic applications of the cell-penetrating HIV-1 Tat peptide.

  2015cited by this paper
• FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.

  2015cited by this paper
• Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth

  2014cited by this paper
• SPDEF Inhibits Prostate Carcinogenesis by Disrupting a Positive Feedback Loop in Regulation of the Foxm1 Oncogene

  2014cited by this paper
• The Inhibition of Stat5 by a Peptide Aptamer Ligand Specific for the DNA Binding Domain Prevents Target Gene Transactivation and the Growth of Breast and Prostate Tumor Cells

  2013cited by this paper
• FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.

  2013cited by this paper
• FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

  2012cited by this paper
• Structural biology and drug discovery of difficult targets: the limits of ligandability.

  2012cited by this paper
• FOXM1: From cancer initiation to progression and treatment.

  2012cited by this paper
• Yeast two-hybrid methods and their applications in drug discovery.

  2012cited by this paper
• Adenovirus‐mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma

  2012cited by this paper
• A designed cell-permeable aptamer-based corepressor peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode.

  2011cited by this paper
• Multiple faces of FoxM1 transcription factor

  2011cited by this paper
• Sub‐angstrom modeling of complexes between flexible peptides and globular proteins

  2010cited by this paper
• Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells

  2010cited by this paper
• Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence

  2010cited by this paper
• The evolution of Fox genes and their role in development and disease

  2009cited by this paper
• FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.

  2008cited by this paper
• Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

  2008cited by this paper
• Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators

  2004cited by this paper
• The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells.

  2004cited by this paper
• The druggable genome

  2002cited by this paper
• Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity

  1999cited by this paper
• An artificial cell-cycle inhibitor isolated from a combinatorial library.

  1998cited by this paper
• On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.

  1997cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function

  1995cited by this paper

• No citing papers are available for this paper.